The DTC model aligns with Most-Favored-Nation pricing, aiming to close the US drug price gap with other high-income countries ...
TrumpRx and a most-favored nation policy won’t lower prices for patients, writes the CEO and co-founder of I-MAK.
PE: Could DTC programs help simplify the drug-pricing system? O’Dell: I’m guessing that the pharmaceutical manufacturers are ...
We need to find ways to lower prescription prices, and it seemed like President Donald Trump was working on a promising ...
That means drug prices rose at a rate that far exceeded the 2024 inflation rate of 3%, the overall healthcare inflation rate ...
Pharmaceutical Technology on MSN
Roche in ongoing discussions with US government over drug pricing, CEO says
Earlier this year, the Trump administration announced the Most Favored Nation (MFN) executive order to tie drug prices in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback